HRES 803 119th Congress
Urging the Director of the Food and Drug Administration to reevaluate the safety of all chemical abortion drugs in light of recent independent studies, and for other purposes.
Latest Action
Referred to the House Committee on Energy and Commerce.
Sponsors
Actions
2025-10-10T00:00:00
Referred to the House Committee on Energy and Commerce.
2025-10-10T00:00:00
Submitted in House
2025-10-10T00:00:00
Submitted in House
Policy Areas
Health
![Rep. Rose, John W. [R-TN-6]](https://bioguide.congress.gov/bioguide/photo/R/R000612.jpg)